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ACUTE MYOCARDIAL INFARCTION - THERAPY 
Megadose Bolus Heparin as Reperfuslon Therapy 
for Acute Myocardial Infarction: Results of the 
HEAP Pilot ~udy 
Froek W,A. Verheugt, Randall C. Marsh, Gerdt Veen, Jean G.F, Bronzwasr, 
Felix Zijlslra. North Colorado Med Ctr, Greeley, CO; Free Univetsi[y 
Hospital, Amsterdam; University Hospital, Nijmegen; Weezenlanden 
Hospital, Zwotle, The Netherlands 
Anglography after thrombolyals for acute myocardial Infarction (AMI) Shows 
better patency when adjunct intravenous (iv) hepadn is used. We wondered, 
if iv hsparin alone also induces reparfusion. 
In the HEAP (Hepadn in Early Patency) pilot study 50 patients (pts) with < 
6 hours (h) signs; (>_ 2 mrs ST t in _> 2 leeds) and symptoms of AMI received a 
single iv bolus of 300 U/kg bepadn, a dose usually given by cardiac surgeons 
pdor to cardiopulmonary bypass. Doses of bolus heparin gwan varied from 
10,000 to 40,000 U. Aspirin (160 mg chewed), but no thrembolytic agent was 
given. Palency was assessed by coronary angiography at 90 minutes (rain) 
after the hepadn bolus. 
In 28/50 (56%) pts TIMI flow 2-3 was seen at 90 rain: TIMI flow 3 in 18 
(36%) pts and TIMI flow 2 in 10 (20%) pts. Pts with < 2 h symptoms (n = 
24) had 67% TIMI flow 2-3 versus 46% in pts with >_ 2 h symptoms (p = 
0.09). Pts with TIMI flow 0-1 underwent direct angiopiasty. At 90 rain aFTT 
exceeded 120 sec in all pta. No significant bleeding was seen. Aspidn 80 mg 
dally was given, as was heparin (aPTT 2.0-2.5) for 48 h. Predischarge anglo 
showed TIMI flow 3 in 15118 (83%) pts. 
Thus, early therapy with high-dose front-loaded hepadn alone can Induce 
fu;! coronary reperfusirm in pts with AMI, especially in early (<2 h) pts. 
This simple, inexpensive and easily antagonizable AMI treatment seems 
to be an attractive altemative to regular thrombolysis, beth in-hospital and 
pro-hospital, and can also be given prior to direct PTCA. 
~ Failure to Improve Outcome in Suspected Acute 
Myocardial Infarction by Pre-Hospital 
Administration of Aspirin 
Robert Greenbaum, Martin Flahen'y, Keen I.an Chan, Dan Shanit. 
Cardiovascular Research Unit Edgwam General Hospital and The London 
Ambulance Acodent and Emergency Service, London, UK 
The I~1S-2 trial has shown that in-hospital treatment of suspected acute 
myocardial infarction (AMI) patients with aspidn is almost as effective as 
treatment with streptokinase in reducing 35 day mortality. We carded out a 
Wospective, randomised, non-blir¢l, controlled study of the effect of adminis- 
tration of a single oral dose of 300 mg aspirin to patients with suspected AMI 
prior to Iransportation to hospital on 35 day mortality. The study was carded 
out over an eighteen month paded by front line ambulance crews based at 
15 London Ambulance Stations. 1850 patients with suspected acute myocar- 
dial infarction aged over 30 years were screened for eligibility. 1652 were 
randomised by the ambulance crews. 999 were allocated to a sttatsgy of 
pre-hospital aspidn and 653 allocated to ~nttol (no aspidn). 980 (98%) of 
those allocated to the treatment group received the medication. At 35 days 
there were 91 deaths in the aspidn group (9.1%) compared with 56 (8.6%) in 
the control group, The absolute increased risk 0.5% (95% confidence inter- 
val -2.26% to 3.3%) was not significant. The majority of deaths were due to 
cardiac causes 77 (85%) in the aspirin group and 47 (84%) in control. There 
were no major side effects atfo'butable to pre-haspital aspidn. Dudng long 
term 24.-,38 months follow up, there were 248 deaths (24.8%) in the aspidn 
group and 163 (25%) in the control group. This 0.2% reduction in the risk 
of death (95% confidence intenral -4.4% to 4.1%) was not signif'canL We 
conclude that a policy of pre~ospitat administration of aspirin to patients wilh 
suspected acute myocardial infarotion is safe but does not improve outcome. 
• Early ePTT Measurements Are Nat • Surrogate for in 
Vivo Thrombin Inhibition Among Patients Receiving 
lnrombolyt ic  Therapy and Adjunctive 
Anticoagulatlon 
Richard G. Beeker, James Hebert, Thomas Hurley, Yuasheng Ma, 
Chdstopher P. Cannon, for the TIMI 5 Hemostasis and Thrombosis Study 
Group. Thrombosis Research Center, Univemity of Maasacl~usetts Mecrcal 
School, Worcester, MA 
The immediate goal of thrombolytic therapy is to rapidly establish and main- 
tain physiologic ¢oronaff adedal blood flow. Adjunctive anticoagulant therapy 
may be required to achieve optimal repeffusion; however, the target aPTT 
value has been difficult o establish. In TIMI 5, measures of thrombln ac- 
tivity (FPA) and thmmbin generation (FI.2) were ol~,ained sedally in 246 
patients receiving accelerated tPA and either hepafin or himd~n. FPA and 
FI.2 levels at 12 and 24 h did not correlate with aPTT at these time points 
in either hepadn or hirudin-treated patients. An aPTT > 90 see (commonly 
considered high-intensity anticeegulation), was not consistently associated 
with decreased thrombin activity or generation. In fact, lhe lowest combin~l 
FPA and F1.2 value was seen with a 12 h aPTT Of ~ 60 
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